A universal influenza vaccine developed with the potential to be longer lasting and more effective than commercially available vaccines is destined for human clinical trials, thanks to a $17.9 million grant from the National Institute of Allergy and Infectious Diseases.
With a grant of $2,355,000 over five years, Marcos Simoes-Costa, assistant professor of molecular biology and genetics, will investigate how the spatial complexity of an organism is generated in early development.
New cellular and molecular processes underlying communication between gut microbes and brain cells have been described for the first time by scientists at Weill Cornell Medicine and Cornell’s Ithaca campus.
Dr. Rainu Kaushal, chair of the Department of Healthcare Policy and Research at Weill Cornell Medicine, has been elected to the National Academy of Medicine
With a pinch of pomp and circumstance, Cornell’s McGovern Center life sciences business incubator recently graduated two companies – Bactana Corp. and Conamix.
Cornell’s New York City campuses also have embraced and encouraged new technology, directions and platforms to increase engagement and boost research and real-world connections.
Turning an MRI exam into a superhero adventure helps prepare children for the test and reduces the need for sedation, according to research by investigators at Weill Cornell Medicine and NewYork-Presbyterian.
The first National Conference on Medical Student Mental Health and Well-Being, hosted by Weill Cornell Medicine, put a spotlight on the increasing rates of psychological distress among medical students.
